Lack of a natural acid that keeps skin healthy could explain why some people are more likely to develop eczema, research suggests.

A new study from Umeå University in Sweden shows that age plays a huge role when it comes to patients' access to psoriasis treatment.

In the first known study to examine the prevalence and treatment of psoriasis in older Americans, experts from the Perelman School of Medicine at the University of Pennsylvania have found that black...

Scientists from the Helmholtz Zentrum München and the Cluster of Excellence "Inflammation at Interfaces" in Kiel in collaboration with researchers and clinicians from 14 different countries have...

Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation, has announced that results from its ongoing phase III LIBERATE™ trial evaluating Otezla® (apremilast), the...

New results from a Phase II head-to-head psoriasis study showed superior efficacy of Boehringer Ingelheim's investigational biologic compound BI 655066*, over ustekinumab.

New research suggests the more severe a person's psoriasis is, the more likely they are to have increased blood vessel inflammation - a condition known as vasculitis.

Individuals with psoriasis - a chronic skin disease - may be twice as likely to develop major depression, according to the results of a new study.

For the first time, people with psoriasis and psoriatic arthritis can contribute directly to the future of research into these chronic, systemic autoimmune diseases through the National Psoriasis...

The National Institute for Health and Care Excellence (NICE) has issued technology appraisal guidance for CosentyxTM (secukinumab).